CIK 0001651308
- Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981209416
- Phone
- +41 616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-03-19 | Liang Howard CFO & Chief Strategy Officer | Sale | −5,200 | $159.62 | $830K | 23,428 |
| 2018-03-19 | Liang Howard CFO & Chief Strategy Officer | Sale | −9,618 | $160.60 | $1.5M | 13,810 |
| 2018-03-19 | Liang Howard CFO & Chief Strategy Officer | Sale | −3,141 | $161.62 | $508K | 10,669 |
| 2018-03-19 | Liang Howard CFO & Chief Strategy Officer | Sale | −5,133 | $162.79 | $836K | 5,536 |
| 2018-03-19 | Liang Howard CFO & Chief Strategy Officer | Sale | −4,636 | $163.48 | $758K | 900 |
| 2018-03-19 | Liang Howard CFO & Chief Strategy Officer | Sale | −900 | $164.36 | $148K | 0 |
| 2018-03-19 | Liang Howard CFO & Chief Strategy Officer | Exercise or conversion · Share Option (Right to Buy) | −313,664 | 4,445,000 | ||
| 2018-03-16 | Liang Howard CFO & Chief Strategy Officer | Exercise or conversion | +10,872 | $6.50 | $71K | 15,872 |
| 2018-03-16 | Liang Howard CFO & Chief Strategy Officer | Sale | −1,000 | $154.95 | $155K | 14,872 |
| 2018-03-16 | Liang Howard CFO & Chief Strategy Officer | Sale | −2,208 | $156.75 | $346K | 12,664 |
| 2018-03-16 | Liang Howard CFO & Chief Strategy Officer | Sale | −7,264 | $157.41 | $1.1M | 5,400 |
| 2018-03-16 | Liang Howard CFO & Chief Strategy Officer | Sale | −400 | $157.98 | $63K | 5,000 |
| 2018-03-16 | Liang Howard CFO & Chief Strategy Officer | Exercise or conversion · Stock Option (Right to Buy) | −141,336 | 4,758,664 | ||
| 2018-03-13 | Glazer Donald W. Director | Gift | −199,992 | 4,327,642 | ||
| 2018-03-02 | OYLER JOHN Chief Executive Officer | Sale | −1,300 | $141.62 | $184K | 24,062 |
| 2018-03-02 | OYLER JOHN Chief Executive Officer | Sale | −2,600 | $142.72 | $371K | 21,462 |
| 2018-03-02 | OYLER JOHN Chief Executive Officer | Sale | −1,546 | $143.64 | $222K | 19,916 |
| 2018-03-02 | OYLER JOHN Chief Executive Officer | Sale | −600 | $145.32 | $87K | 19,316 |
| 2018-03-02 | OYLER JOHN Chief Executive Officer | Sale | −200 | $146.25 | $29K | 19,116 |
| 2018-03-02 | OYLER JOHN Chief Executive Officer | Sale | −700 | $147.31 | $103K | 18,416 |
Page 112 of 123 · 2,455 trades